midazolam / fentanyl combined in EBUS-TBNA
Phase 3
- Conditions
- ung cancer, Mediastinal tumor, Mediastinal lymphadenopathy
- Registration Number
- JPRN-jRCTs051210131
- Lead Sponsor
- Tachihara Motoko
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 98
Inclusion Criteria
(1) over20 years old
(2) EBUS-TBNA is scheduled to be performed for the purpose of biopsy of mediastinal lesions.
(3) Document consent can be obtained by the patient regarding participation in this study
Exclusion Criteria
(1) drug hypersensitivity constitution such as allergies to the drugs used in this study.
(2) Have acute narrow-angle glaucoma
(3) Have myasthenia gravis
(4) Have uncontrollable bronchial asthma
(5) Being in a spastic state
(6) Taking HIV protease inhibitor or nalmefene
(7) The use of muscle relaxants is contraindicated
(8) Prone to respiratory depression such as coma due to head injury, brain tumor, etc.
(9) Taking opioids
(10) Others who are judged to be inappropriate by the person in charge of this test
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method